Search
for
Sort by
Research 91–120 of 1000+
- Hair disorders in patients with cancer
- Human hair follicle organ culture: theory, application and perspectives
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Adverse effects of common medications on male fertility
- Apoptosis and cutaneous biology
- Recent Advances in the Structural Design of Photosensitive Agent Formulations Using “Soft” Colloidal Nanocarriers
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Hair and nail involvement in lupus erythematosus
- (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production
- Male fertility and skin diseases
- A Study on the Utilization of Dendropanax morbifera Lev. Leaf Extract for Material of Functional Cosmetics and Hair Growth Products
- Disorders of hair
- Plant Extracts in Skin Care Products
- Cancer Treatments and Alopecia: A Systematic Review
- Hair and scalp disorders
- Alopecia Areata
- Immune Microenvironment of Hair Follicles in Tumor Immunotherapy
- Meta-Analysis of Gene Expression Reveals the Core Transcriptomic Profile of Lesional Scalp in Alopecia Areata
- Dissolving microneedles: an advanced approach for transdermal drug delivery
- Interactions between Damaged Hair Keratin and Juglone as a Possible Restoring Agent: A Vibrational and Scanning Electron Microscopy Study
- 1317 Nicotinic acid suppresses sebaceous lipid synthesis of human sebocytes via activating hydroxycarboxylic acid receptor 2 (HCA2)
- Systemic Corticosteroids in Vitiligo
- The pathogenesis of alopecia areata
- Sodium chloride reduces growth and cytosolic calcium, but does not affect cytosolic pH, in root hairs of Arabidopsis thaliana L.
- Repurposing of Various Current Medicines as Radioprotective Agents
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- The role of lymphocytes in the development and treatment of alopecia areata
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- The transdermal inhibition of melanogenesis by a cell-membrane-permeable peptide delivery system based on poly-arginine